Premium
Predictors of response to anti‐IL‐5 biologics
Author(s) -
Nair Parameswaran
Publication year - 2020
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13926
Subject(s) - mepolizumab , medicine , benralizumab , exacerbation , asthma , eosinophil , immunology , eosinophilia , interleukin 5 , eosinophil cationic protein , asthma exacerbations , cytokine , allergic inflammation , interleukin